EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Systematic prioritization of potential therapeutic targets for glomerulonephritis using multi-omics Mendelian randomization

Guoqiang Li, Fu Jianhan, Jiashu Gu, Yinhuai Wang, Jiachen Liu, Dong Yang, Dianjie Zeng iD, Pengcheng Zhao

PLOS Computational Biology · 2026

DOI: 10.1371/journal.pcbi.1014174 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Computational Biology, 2026. Verfasst von Guoqiang Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou 450008, China. Hauptthemen laut MEDLINE: Glomerulonephritis, Mendelian Randomization Analysis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Special Fund for the Construction of Innovative Provinces in Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glomerulonephritis (GN) is an immune-mediated kidney disorder that causes glomerular injury, progressive renal dysfunction, and end-stage kidney disease. Traditional treatments such as corticosteroids and immunosuppressants are limited by variable efficacy and severe adverse effects, highlighting the need for novel therapeutic targets and personalized strategies. We performed a systematic multi-omics Mendelian randomization (MR) analysis applying established proteomic and transcriptomic quantitative trait loci (pQTL/eQTL) resources to genome-wide association studies (GWAS) of four GN subtypes: acute, chronic, IgA nephropathy, and membranous nephropathy. Bayesian colocalization was used to strengthen causal inference, while independent replication and meta-analysis were conducted using the FinnGen cohort. Mouse knockout phenotypes, drug reposition, and computational pharmacology algorithm were applied to evaluate translational potential. Proteomic-wide MR revealed MTR as protective in chronic GN and HCK as a risk factor for membranous nephropathy, whereas CD302 and CDKN1B showed protective effects. Transcriptomic-wide MR identified candidate genes across GN subtypes: RECQL , BRSK2 , and MGP in acute GN; AFM , CFHR5 , and EPHB2 in chronic GN; IL6R , MBL2 , and PRSS3 in IgA nephropathy; and TIMP4 , HCK , and PEAR1 in membranous nephropathy. Bayesian colocalization analysis provided strong support for shared causal variants (PPH4 > 0.8) for HCK , CD302 , TIMP4 , PEAR1 , PARP1 , and FHIT . Replication and meta-analysis in the FinnGen cohort provided additional consistency across datasets, while downstream translational annotations highlighted IL6R , MBL2 , C5 , and CD55 as potential hub targets within immune and complement-related pathways. This integrative multi-omics study provides novel insights into the genetic architecture and therapeutic landscape of GN, identifying potential therapeutic targets that may inform precision nephrology and drug repurposing. Notably, most targets supported by colocalization, mouse knockout phenotypes, and drug repurposing evidence were predominantly identified in membranous nephropathy, suggesting a particularly tractable genetic and therapeutic architecture for this subtype.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlomerulonephritisMendelian Randomization AnalysisAnimalsHumansGenome-Wide Association StudyMiceMultiomicsProteomicsQuantitative Trait LociBayes TheoremTranscriptomeMice, KnockoutComputational Biology

Autor:innen und Institutionen

  • Department of Urology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou 450008, China.
  • Department of Urology, Sun yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
  • Department of Urology, The Second Xiangya Hospital at Central South University, Changsha, Hunan, China.
  • Xiangya School of Medicine, Central South University, Changsha, Hunan, China.
  • Department of Nephrology, The Second Xiangya Hospital at Central South University, Changsha, Hunan, China.

ORCID-Profile: Dianjie Zeng

Förderung

  • Special Fund for the Construction of Innovative Provinces in Hunan Province

Zitieren

APA

Li, G., Jianhan, F., Gu, J., Wang, Y., Liu, J., Yang, D., Zeng, D., & Zhao, P. (2026). Systematic prioritization of potential therapeutic targets for glomerulonephritis using multi-omics Mendelian randomization. PLOS Computational Biology. https://doi.org/10.1371/journal.pcbi.1014174

Vancouver

Li G, Jianhan F, Gu J, Wang Y, Liu J, Yang D, et al. Systematic prioritization of potential therapeutic targets for glomerulonephritis using multi-omics Mendelian randomization. PLOS Computational Biology. 2026. doi:10.1371/journal.pcbi.1014174

BibTeX
@article{Li2026,
  author = {Li, Guoqiang and Jianhan, Fu and Gu, Jiashu and Wang, Yinhuai and Liu, Jiachen and Yang, Dong and Zeng, Dianjie and Zhao, Pengcheng},
  title = {Systematic prioritization of potential therapeutic targets for glomerulonephritis using multi-omics Mendelian randomization},
  journal = {PLOS Computational Biology},
  year = {2026},
  doi = {10.1371/journal.pcbi.1014174}
}
Kostenlos starten →